The role of the lipid abnormalities as a risk factor for @entity64 remains controversial; very likely because only the standard lipid fractions are measured and because different causes of @entity64 are not considered. LDL phenotype B promotes @entity731 and is recognized as a risk factor for @entity741 , but its prevalence in @entity385 of distinct causes is unknown. Therefore we designed the study to investigate the prevalence of LDL phenotype B in @entity64 survivors with large @entity6249 ( @entity6249 ) and to establish the relationship between LDL phenotypes and basic lipid fractions in this group of @entity1 . 59 @entity1 (24 @entity1 with @entity66 and 35 @entity1 with @entity6249 ) being at least 3 months after @entity385 were included into the study. 30 sex- and age-matched subject served as controls. The concentrations of total @entity165 , HDL- and LDL- @entity165 , as well as @entity1674 were measured and the LDL phenotype was determined using the @entity27801 density gradient ultracentrifugation. The LDL phenotype B was more frequent in @entity1 with @entity66 (67%, p < 0.05) compared to @entity1 with @entity6249 and with controls. LDL phenotype B was also more frequent in @entity1 with @entity6249 (40%) and in all @entity64 survivors combined (51%), when compared with control group (17%, p < 0.05; chi-square test). Among @entity64 survivors, controls and studied subjects as a whole, those with LDL phenotype B revealed the lower concentration of HDL- @entity165 (1.19 +/- 0.33 vs. 1.46 +/- 0.42; 1.16 +/- 0.29 vs. 1.53 +/- 0.3 and 1.19 +/- 0.32 vs. 1.49 +/- 0.37, respectively; p < 0.05, Student t-test) when compared with carriers of LDL A phenotype. The LDL phenotype B is more frequent in @entity385 compared to controls, and within the group of @entity64 survivors, @entity34893 is more prevalent in @entity1 with @entity66 . The LDL phenotype B is associated with lower concentration of HDL- @entity165 .

[LDL phenotype A and B in XXXX ].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity34893 :: ('9382', 'Gene') :: ['LDL B'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity66 :: ('MESH:D004194', 'Disease') :: ['LVD'] @entity6249 :: ('MESH:D059345', 'Disease') :: ['SVD', 'vessel disease (LVD) or small vessel disease'] @entity1674 :: ('MESH:D014280', 'Chemical') :: ['triglycerides'] @entity27801 :: ('MESH:C039004', 'Chemical') :: ['potassium bromide'] @entity741 :: ('MESH:D017202', 'Disease') :: ['ischemic heart disease'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherogenesis'] @entity165 :: ('MESH:D002784', 'Chemical') :: ['cholesterol'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke', 'ischemic stroke survivors']
@entity385 :: (MESH:D002544,Disease) :: ['ischemic stroke']
